Back
Annaly Capital Management Vs. Spyre Therapeutics Industry Stock Comparison
Sell
38
NLY
Annaly Capital Management
Last Price:
19.90
Seasonality Move:
-2.01%
Sell
27
SYRE
Spyre Therapeutics
Last Price:
23.06
Seasonality Move:
49.76%
Sell
38
Annaly Capital Management (NLY)
is a Sell
Is Annaly Capital Management a Buy, Sell or Hold?
- The current Annaly Capital Management [NLY] share price is $20.05. The Score for NLY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- NLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $22.90. The Score for SYRE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NLY Stock Price Chart
What is Annaly Capital Management's stock price today?
-
The Annaly Capital Management share price today is $20.05
The current trend is moderately bullish and NLY is experiencing selling pressure, which indicates risk of future bearish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $22.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
NLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 55.15 | Buy |
Chaikin Money Flow: | -2431883 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.53 - 20.11) | Buy |
Bollinger Bands (100): | (18.73 - 19.95) | Buy |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 28.27 | Sell |
Chaikin Money Flow: | -408420 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.66 - 36.8) | Sell |
Bollinger Bands (100): | (27.1 - 39.22) | Sell |
NLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.07 | Sell |
20-day SMA: | 19.83 | Buy |
50-day SMA: | 19.47 | Buy |
200-day SMA: | 18.92 | Buy |
8-day EMA: | 20.01 | Buy |
20-day EMA: | 19.9 | Buy |
50-day EMA: | 19.66 | Buy |
200-day EMA: | 19.4 | Buy |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.49 | Sell |
20-day SMA: | 31.58 | Sell |
50-day SMA: | 33.73 | Sell |
200-day SMA: | 24.46 | Sell |
8-day EMA: | 26.49 | Sell |
20-day EMA: | 30.15 | Sell |
50-day EMA: | 32.53 | Sell |
200-day EMA: | 27.05 | Sell |
Annaly Capital Management Earnings Growth & NLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.05 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Annaly Capital Management Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |